Home  »  Finance   »  Which Institutions Own Shares In Sorrento Therapeu...

Which Institutions Own Shares In Sorrento Therapeutics Inc. (SRNE)?

Sorrento Therapeutics Inc. (NASDAQ: SRNE) is -65.16% lower on its value in year-to-date trading and has touched a low of $1.15 and a high of $8.20 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The SRNE stock was last observed hovering at around $1.64 in the last trading session, with the day’s loss setting it -0.02%.

Currently trading at $1.62, the stock is -20.47% and -30.35% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.7 million and changing -1.22% at the moment leaves the stock -40.34% off its SMA200. SRNE registered -79.72% loss for a year compared to 6-month loss of -33.88%.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .

Sponsored

The stock witnessed a -13.83% gain in the last 1 month and extending the period to 3 months gives it a -28.95%, and is -22.49% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.94% over the week and 8.39% over the month.

Sorrento Therapeutics Inc. (SRNE) has around 799 employees, a market worth around $814.68M and $55.00M in sales. Distance from 52-week low is 40.87% and -80.24% from its 52-week high. The company has generated returns on investments over the last 12 months (-169.30%).

Sorrento Therapeutics Inc. (SRNE) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for Sorrento Therapeutics Inc. (SRNE) is a “Buy”. 1 analysts offering their recommendations for the stock have an average rating of 2.00, where 0 rate it as a Hold and 0 think it is a “Overweight”. 1 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

Sorrento Therapeutics Inc. is expected to release its quarterly report on 11/03/2022.The EPS is expected to shrink by -11.90% this year

Sorrento Therapeutics Inc. (SRNE) Top Institutional Holders

The shares outstanding are 449.95M, and float is at 424.79M with Short Float at 12.74%.

Sorrento Therapeutics Inc. (SRNE) Insider Activity

A total of 3 insider transactions have happened at Sorrento Therapeutics Inc. (SRNE) in the last six months, with sales accounting for 0 and purchases happening 3 times. The most recent transaction is an insider purchase by Ji Henry, the company’s. SEC filings show that Ji Henry bought 88,888 shares of the company’s common stock on Sep 07 at a price of $2.02 per share for a total of $0.18 million. Following the purchase, the insider now owns 4.77 million shares.

Sorrento Therapeutics Inc. disclosed in a document filed with the SEC on Sep 06 that Ji Henry () bought a total of 55,555 shares of the company’s common stock. The trade occurred on Sep 06 and was made at $1.96 per share for $0.11 million. Following the transaction, the insider now directly holds 4.68 million shares of the SRNE stock.

Still, SEC filings show that on Aug 26, Ji Henry () acquired 33,333 shares at an average price of $2.11 for $70333.0. The insider now directly holds 2,121,362 shares of Sorrento Therapeutics Inc. (SRNE).

Sorrento Therapeutics Inc. (SRNE): Who are the competitors?

The company’s main competitors (and peers) include Exelixis Inc. (EXEL) that is trading -17.97% down over the past 12 months and Karyopharm Therapeutics Inc. (KPTI) that is -24.55% lower over the same period.

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts

111365

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.